Evidence map›Paper›PMID 40151163›Full record

ArticleJournal of cancer epidemiology2024

Cancer Risk in Nepal: An Analysis from Population-Based Cancer Registry of Urban, Suburban, and Rural Regions.

Uma Kafle Dahal, Kopila Khadka, Kiran Neupane, Sandhya Chapagain Acharya, Anjani Kumar Jha, Pradip Gyanwali, Gehanath Baral

Abstract read
In one paragraph

Article in Journal of cancer epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. "I felt as though my life had come to an end": lived experiences of adolescents and young adults with cancer in Nepal.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Uma Kafle DahalNepal Health Research Council, Ramshah Path, Kathmandu, Nepal.ORCID https://orcid.org/0009-0008-2074-7597
Kopila KhadkaNepal Health Research Council, Ramshah Path, Kathmandu, Nepal.ORCID https://orcid.org/0009-0004-1346-7272
Kiran NeupaneNepal Health Research Council, Ramshah Path, Kathmandu, Nepal.
Sandhya Chapagain AcharyaDepartment of Clinical Oncology, National Academy of Medical Science, NAMS, Bir Hospital, Kathmandu, Nepal.
Anjani Kumar JhaDepartment of Radiation Oncology, Kathmandu Cancer Center, Tathali, Bhaktapur, Nepal.
Pradip GyanwaliNepal Health Research Council, Ramshah Path, Kathmandu, Nepal.
Gehanath BaralNepal Health Research Council, Ramshah Path, Kathmandu, Nepal.ORCID https://orcid.org/0000-0002-3319-5516

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cancer is one of the leading causes of death globally. The low and middle-income countries (LMICs) cover a major share of the global cancer burden; however, most of the LMICs including Nepal still lack national cancer control and prevention strategies. Since 1 Methods: Data regarding incidence and mortality was collected by the PBCR in Nepal. Indirect and direct methods were used to collect data from health facilities and communities, respectively. Registered cases of incidence and mortality from 1 Result: Age-adjusted incidence (AAR) and mortality rates in Nepal were found 65.6 and 29 per 100,000 people, respectively. Every 1 in 14 men and 1 in 13 women were at risk of getting, and 1 in 28 men and 1 in 33 women were dying of cancer before age 75 in Nepal. The highest risk was found for lung cancer (1 in 80) followed by stomach and mouth among men, and in women, breast cancer (1 in 76) was the commonest among all followed by lung and cervix. Conclusion: Cancer has been growing as one of the major public health burdens in Nepal. Screening with cost-effective technology, awareness, and vaccination against HPV should be a government priority including revision of treatment protocols for cancers that have higher mortality to prevent further preventable life loss from malignancies.

Identifiers

PMID40151163
PMCPMC11949594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.